Immuneering (IMRX) Earnings Date & Reports

Immuneering Corp is a biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMRX is expected to report earnings to fall 15.52% to -49 cents per share on May 13

Q1'25

Est.

$-0.49

Q4'24

Missed

by $0.13

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.01

The last earnings report on March 20 showed earnings per share of -57 cents, missing the estimate of -44 cents. With 50.47K shares outstanding, the current market capitalization sits at 49.66M.

View a ticker or compare two or three

Compare

IMRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMRX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

245 Main Street

Phone

+1 617 500-8080

Employees

Web

https://www.immuneering.com